Advertisement
Screener

SCPHARMACEUTICALS INC. Net Income

SCPHARMACEUTICALS INC. Net Income

SCPHARMACEUTICALS INC. reported Net Income of -$18.02 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2025-08-07

  • SCPHARMACEUTICALS INC. net income (loss) attributable to parent for the quarter ending 2025-06-30 was -$18.02M.
  • SCPHARMACEUTICALS INC. net income (loss) attributable to parent for the quarter ending 2025-03-31 was -$19.74M.
  • SCPHARMACEUTICALS INC. net income (loss) attributable to parent for the quarter ending 2024-12-31 was -$18.84M.
  • SCPHARMACEUTICALS INC. net income (loss) attributable to parent for the quarter ending 2024-09-30 was -$35.10M.
  • SCPHARMACEUTICALS INC. net income (loss) attributable to parent for fiscal 2024 was -$85.15M.
  • SCPHARMACEUTICALS INC. net income (loss) attributable to parent for fiscal 2023 was -$54.81M.
  • SCPHARMACEUTICALS INC. net income (loss) attributable to parent for fiscal 2022 was -$36.84M.
  • SCPHARMACEUTICALS INC. net income (loss) attributable to parent for fiscal 2021 was -$28.03M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 month
2025-06-30-$18.02M
10-Q · filed 2025-08-07
-$37.77M
10-Q · filed 2025-08-07
-$56.61M
derived: sum of 3 quarters · filed 2025-08-07
-$91.72M
derived: sum of 4 quarters · filed 2025-08-07
2025-03-31-$19.74M
10-Q · filed 2025-05-14
-$38.59M
derived: sum of 2 quarters · filed 2025-05-14
-$73.69M
derived: sum of 3 quarters · filed 2025-05-14
-$90.78M
derived: sum of 4 quarters · filed 2025-08-07
2024-12-31-$18.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19
-$53.95M
derived: sum of 2 quarters · filed 2025-03-19
-$71.04M
derived: sum of 3 quarters · filed 2025-08-07
-$85.15M
10-K · filed 2025-03-19
2024-09-30-$35.10M
10-Q · filed 2024-11-13
-$52.20M
derived: sum of 2 quarters · filed 2025-08-07
-$66.30M
10-Q · filed 2024-11-13
-$80.11M
derived: sum of 4 quarters · filed 2025-08-07
2024-06-30-$17.09M
10-Q · filed 2025-08-07
-$31.20M
10-Q · filed 2025-08-07
-$45.01M
derived: sum of 3 quarters · filed 2025-08-07
-$60.64M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31-$14.11M
10-Q · filed 2025-05-14
-$27.92M
derived: sum of 2 quarters · filed 2025-05-14
-$43.55M
derived: sum of 3 quarters · filed 2025-05-14
-$57.71M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31-$13.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19
-$29.45M
derived: sum of 2 quarters · filed 2025-03-19
-$43.60M
derived: sum of 3 quarters · filed 2025-03-19
-$54.81M
10-K · filed 2025-03-19
2023-09-30-$15.63M
10-Q · filed 2024-11-13
-$29.79M
derived: sum of 2 quarters · filed 2024-11-13
-$41.00M
10-Q · filed 2024-11-13
-$50.25M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30-$14.15M
10-Q · filed 2024-08-14
-$25.36M
10-Q · filed 2024-08-14
-$34.61M
derived: sum of 3 quarters · filed 2024-08-14
-$44.77M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$11.21M
10-Q · filed 2024-05-14
-$20.46M
derived: sum of 2 quarters · filed 2024-05-14
-$30.62M
derived: sum of 3 quarters · filed 2024-05-14
-$40.32M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31-$9.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13
-$19.41M
derived: sum of 2 quarters · filed 2024-03-13
-$29.11M
derived: sum of 3 quarters · filed 2024-03-13
-$36.84M
10-K · filed 2024-03-13
2022-09-30-$10.16M
10-Q · filed 2023-11-08
-$19.86M
derived: sum of 2 quarters · filed 2023-11-08
-$27.59M
10-Q · filed 2023-11-08
-$34.91M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30-$9.70M
10-Q · filed 2023-08-10
-$17.43M
10-Q · filed 2023-08-10
-$24.75M
derived: sum of 3 quarters · filed 2023-08-10
-$31.30M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$7.73M
10-Q · filed 2023-05-10
-$15.05M
derived: sum of 2 quarters · filed 2023-05-10
-$21.60M
derived: sum of 3 quarters · filed 2023-05-10
-$28.66M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31-$7.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22
-$13.87M
derived: sum of 2 quarters · filed 2023-03-22
-$20.93M
derived: sum of 3 quarters · filed 2023-03-22
-$28.03M
10-K · filed 2023-03-22
2021-09-30-$6.55M
10-Q · filed 2022-11-09
-$13.61M
derived: sum of 2 quarters · filed 2022-11-09
-$20.72M
10-Q · filed 2022-11-09
-$28.50M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30-$7.06M
10-Q · filed 2022-08-09
-$14.16M
10-Q · filed 2022-08-09
-$21.95M
derived: sum of 3 quarters · filed 2022-08-09
-$30.99M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31-$7.10M
10-Q · filed 2022-05-16
-$14.89M
derived: sum of 2 quarters · filed 2022-05-16
-$23.92M
derived: sum of 3 quarters · filed 2022-05-16
-$32.22M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$7.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22
-$16.82M
derived: sum of 2 quarters · filed 2022-03-22
-$25.12M
derived: sum of 3 quarters · filed 2022-03-22
-$32.21M
10-K · filed 2022-03-22
2020-09-30-$9.04M
10-Q · filed 2021-11-09
-$17.33M
derived: sum of 2 quarters · filed 2021-11-09
-$24.43M
10-Q · filed 2021-11-09
-$35.24M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$8.29M
10-Q · filed 2021-08-11
-$15.39M
10-Q · filed 2021-08-11
-$26.20M
derived: sum of 3 quarters · filed 2021-08-11
-$32.41M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31-$7.09M
10-Q · filed 2021-05-12
-$17.91M
derived: sum of 2 quarters · filed 2021-05-12
-$24.11M
derived: sum of 3 quarters · filed 2021-05-12
-$31.37M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31-$10.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23
-$17.02M
derived: sum of 2 quarters · filed 2021-03-23
-$24.28M
derived: sum of 3 quarters · filed 2021-03-23
-$33.00M
10-K · filed 2021-03-23
2019-09-30-$6.21M
10-Q · filed 2020-11-16
-$13.46M
derived: sum of 2 quarters · filed 2020-11-16
-$22.18M
10-Q · filed 2020-11-16
-$27.28M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30-$7.25M
10-Q · filed 2020-08-13
-$15.97M
10-Q · filed 2020-08-13
-$21.07M
derived: sum of 3 quarters · filed 2020-08-13
-$26.84M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31-$8.72M
10-Q · filed 2020-05-12
-$13.82M
derived: sum of 2 quarters · filed 2020-05-12
-$19.58M
derived: sum of 3 quarters · filed 2020-05-12
-$29.43M
derived: sum of 4 quarters · filed 2020-05-12
2018-12-31-$5.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24
-$10.86M
derived: sum of 2 quarters · filed 2020-03-24
-$20.71M
derived: sum of 3 quarters · filed 2020-03-24
-$29.44M
10-K · filed 2020-03-24
2018-09-30-$5.76M
10-Q · filed 2019-11-12
-$15.61M
derived: sum of 2 quarters · filed 2019-11-12
-$24.34M
10-Q · filed 2019-11-12
-$31.22M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$9.85M
10-Q · filed 2019-08-07
-$18.58M
10-Q · filed 2019-08-07
-$25.46M
derived: sum of 3 quarters · filed 2019-08-07
-$30.95M
derived: sum of 4 quarters · filed 2019-08-07
2018-03-31-$8.73M
10-Q · filed 2019-05-08
-$15.61M
derived: sum of 2 quarters · filed 2019-05-08
-$21.10M
derived: sum of 3 quarters · filed 2019-05-08
-$27.64M
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31-$6.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-21
-$12.37M
derived: sum of 2 quarters · filed 2019-03-21
-$18.91M
derived: sum of 3 quarters · filed 2019-03-21
-$23.82M
10-K · filed 2019-03-21
2017-09-30-$5.49M
10-Q · filed 2018-11-13
-$12.03M
derived: sum of 2 quarters · filed 2018-11-13
-$16.94M
10-Q · filed 2018-11-13
2017-06-30-$6.54M
10-Q · filed 2018-08-14
-$11.45M
10-Q · filed 2018-08-14
2017-03-31-$4.91M
10-Q · filed 2018-05-07
2016-12-31-$24.38M
10-K · filed 2019-03-21